These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

228 related articles for article (PubMed ID: 11465873)

  • 1. Caspofungin.
    Keating GM; Jarvis B
    Drugs; 2001; 61(8):1121-9; discussion 1130-1. PubMed ID: 11465873
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Caspofungin: a review of its use in oesophageal candidiasis, invasive candidiasis and invasive aspergillosis.
    Keating G; Figgitt D
    Drugs; 2003; 63(20):2235-63. PubMed ID: 14498760
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Caspofungin: a review of its use in the treatment of fungal infections.
    McCormack PL; Perry CM
    Drugs; 2005; 65(14):2049-68. PubMed ID: 16162025
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Caspofungin acetate for treatment of invasive fungal infections.
    Pacetti SA; Gelone SP
    Ann Pharmacother; 2003 Jan; 37(1):90-8. PubMed ID: 12503942
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Caspofungin.
    Deresinski SC; Stevens DA
    Clin Infect Dis; 2003 Jun; 36(11):1445-57. PubMed ID: 12766841
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Caspofungin: the first representative of a new antifungal class.
    Letscher-Bru V; Herbrecht R
    J Antimicrob Chemother; 2003 Mar; 51(3):513-21. PubMed ID: 12615851
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Caspofungin: pharmacology, safety and therapeutic potential in superficial and invasive fungal infections.
    Groll AH; Walsh TJ
    Expert Opin Investig Drugs; 2001 Aug; 10(8):1545-58. PubMed ID: 11772269
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Caspofungin: a major breakthrough in treatment of systemic fungal infections.
    Agarwal MB; Rathi SA; Ratho N; Subramanian R
    J Assoc Physicians India; 2006 Dec; 54():943-8. PubMed ID: 17334012
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Caspofungin: first approved agent in a new class of antifungals.
    Johnson MD; Perfect JR
    Expert Opin Pharmacother; 2003 May; 4(5):807-23. PubMed ID: 12740003
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Safety and tolerability of caspofungin acetate in the treatment of fungal infections.
    Sable CA; Nguyen BY; Chodakewitz JA; DiNubile MJ
    Transpl Infect Dis; 2002 Mar; 4(1):25-30. PubMed ID: 12123423
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Caspofungin in the treatment of candidosis and aspergillosis.
    Maertens J; Boogaerts M
    Int J Infect Dis; 2003 Jun; 7(2):94-101. PubMed ID: 12839709
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacological properties and clinical efficacy of a recently licensed systemic antifungal, caspofungin.
    Maschmeyer G; Glasmacher A
    Mycoses; 2005 Jul; 48(4):227-34. PubMed ID: 15982202
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Echinocandin antifungal drugs.
    Denning DW
    Lancet; 2003 Oct; 362(9390):1142-51. PubMed ID: 14550704
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Caspofungin: an echinocandin antifungal agent.
    Stone EA; Fung HB; Kirschenbaum HL
    Clin Ther; 2002 Mar; 24(3):351-77; discussion 329. PubMed ID: 11952021
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Caspofungin acetate: an antifungal agent.
    Hoang A
    Am J Health Syst Pharm; 2001 Jul; 58(13):1206-14; quiz 1215-7. PubMed ID: 11449878
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A prospective, multicenter study of caspofungin for the treatment of documented Candida or Aspergillus infections in pediatric patients.
    Zaoutis TE; Jafri HS; Huang LM; Locatelli F; Barzilai A; Ebell W; Steinbach WJ; Bradley J; Lieberman JM; Hsiao CC; Seibel N; Laws HJ; Gamba M; Petrecz M; Taylor AF; Strohmaier KM; Chow JW; Kartsonis NA; Ngai AL
    Pediatrics; 2009 Mar; 123(3):877-84. PubMed ID: 19255017
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The first echinocandin: caspofungin.
    Cornely OA; Schmitz K; Aisenbrey S
    Mycoses; 2002; 45 Suppl 3():56-60. PubMed ID: 12690973
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Caspofungin--a new therapeutic option for oropharyngeal candidiasis.
    Garbino J
    Clin Microbiol Infect; 2004 Mar; 10(3):187-9. PubMed ID: 15008939
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of caspofungin and amphotericin B for invasive candidiasis.
    Mora-Duarte J; Betts R; Rotstein C; Colombo AL; Thompson-Moya L; Smietana J; Lupinacci R; Sable C; Kartsonis N; Perfect J;
    N Engl J Med; 2002 Dec; 347(25):2020-9. PubMed ID: 12490683
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The pharmacology and clinical use of caspofungin.
    Hope WW; Shoham S; Walsh TJ
    Expert Opin Drug Metab Toxicol; 2007 Apr; 3(2):263-74. PubMed ID: 17428155
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.